应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
09989 海普瑞
未开盘 07-22 16:08:56
3.460
+0.040
+1.17%
最高
3.510
最低
3.420
成交量
68.70万
今开
3.430
昨收
3.420
日振幅
2.63%
总市值
50.77亿
流通市值
7.62亿
总股本
14.67亿
成交额
238.45万
换手率
0.31%
流通股本
2.20亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
智通AH统计|7月19日
智通财经 · 07-19
智通AH统计|7月19日
港股异动 | 海普瑞(09989)涨超4% 上半年净利预增超4.2倍 依诺肝素钠制剂销量稳增
智通财经 · 07-18
港股异动 | 海普瑞(09989)涨超4% 上半年净利预增超4.2倍 依诺肝素钠制剂销量稳增
海普瑞7月16日获融资净买入1685万元 环比增加1941.90%
自选股智能写手 · 07-18
海普瑞7月16日获融资净买入1685万元 环比增加1941.90%
单抗概念盘中拉升,海普瑞涨2.22%
自选股智能写手 · 07-18
单抗概念盘中拉升,海普瑞涨2.22%
北向资金7月17日净卖出海普瑞41.08万股 连续3日减持
自选股智能写手 · 07-18
北向资金7月17日净卖出海普瑞41.08万股 连续3日减持
净利同比暴涨4.2倍的海普瑞(09989),却只能在肝素周期中沉浮?
智通财经 · 07-16
净利同比暴涨4.2倍的海普瑞(09989),却只能在肝素周期中沉浮?
昨日该医药股“一”字涨停,上半年净利大幅预增逾4倍!
中国制药网 · 07-16
昨日该医药股“一”字涨停,上半年净利大幅预增逾4倍!
海普瑞(002399)7月15日主力资金净买入223.19万元
证券之星 · 07-16
海普瑞(002399)7月15日主力资金净买入223.19万元
智通港股解盘 | 特朗普遇袭加大全球避险情绪 碧桂园(02007)或迎来转机
智通财经 · 07-15
智通港股解盘 | 特朗普遇袭加大全球避险情绪 碧桂园(02007)或迎来转机
肝素价格仍在低位,海普瑞遭遇诈骗后上半年却扭亏了
界面 · 07-15
肝素价格仍在低位,海普瑞遭遇诈骗后上半年却扭亏了
海普瑞:上半年净利预增超 4 倍 3.78 港元
和讯网 · 07-15
海普瑞:上半年净利预增超 4 倍 3.78 港元
海普瑞股价上涨12.65% 市值涨1.02亿港元
自选股智能写手 · 07-15
海普瑞股价上涨12.65% 市值涨1.02亿港元
中报预增概念股继续活跃 台华新材、海普瑞双双竞价涨停
金融界 · 07-15
中报预增概念股继续活跃 台华新材、海普瑞双双竞价涨停
南向资金7月12日净买入海普瑞10.10万股 连续3日增持
自选股智能写手 · 07-15
南向资金7月12日净买入海普瑞10.10万股 连续3日增持
海普瑞(09989)上涨14.81%,报3.72元/股
金融界 · 07-15
海普瑞(09989)上涨14.81%,报3.72元/股
港股异动 | 海普瑞(09989)涨超14% 预计上半年净利同比增超4.2倍
智通财经 · 07-15
港股异动 | 海普瑞(09989)涨超14% 预计上半年净利同比增超4.2倍
海普瑞上半年净利预增420.7%至495.72%
北京商报 · 07-12
海普瑞上半年净利预增420.7%至495.72%
海普瑞预计上半年净利润增长420.70%—495.72%
新京报 · 07-12
海普瑞预计上半年净利润增长420.70%—495.72%
海普瑞(002399.SZ)发预增,预计上半年净利润6.42亿元–7.35亿元,同比这种420.70%-495.72%
智通财经 · 07-12
海普瑞(002399.SZ)发预增,预计上半年净利润6.42亿元–7.35亿元,同比这种420.70%-495.72%
海普瑞:上半年净利预增420.7%~495.7%
每日经济新闻 · 07-12
海普瑞:上半年净利预增420.7%~495.7%
公司概况
公司名称:
海普瑞
所属市场:
SEHK
上市日期:
--
主营业务:
深圳市海普瑞药业集团股份有限公司是一家中国制药公司。该公司经营四个分部。药物制剂分部从事生产和销售抗凝血及抗血栓药物制剂,包括依诺肝素钠注射液和肝素钠注射液。Active Pharmaceutical Ingredient(API)分部从事生产和销售API产品,包括肝素钠API和依诺肝素钠API。Contract Development Manufacturing Organization(CDMO)分部提供药物开发所需要的全周期服务,包括研发、生产、质量管理、项目管理以及商业化生产。该公司还经营其他分部。
发行价格:
--
{"stockData":{"symbol":"09989","market":"HK","secType":"STK","nameCN":"海普瑞","latestPrice":3.46,"timestamp":1721635736036,"preClose":3.42,"halted":0,"volume":687000,"delay":0,"floatShares":220094500,"shares":1467296204,"eps":-0.57100415,"marketStatus":"未开盘","marketStatusCode":0,"change":0.04,"latestTime":"07-22 16:08:56","open":3.43,"high":3.51,"low":3.42,"amount":2384465,"amplitude":0.026316,"askPrice":3.48,"askSize":20000,"bidPrice":3.46,"bidSize":68500,"shortable":0,"etf":0,"ttmEps":-0.5066651115664418,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721698200000},"adr":0,"listingDate":1594137600000,"adjPreClose":3.42,"dividendRate":0.031155,"openAndCloseTimeList":[[1721611800000,1721620800000],[1721624400000,1721635200000]],"volumeRatio":0.19368480406850566,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"002399","market":"SZ","secType":"STK","nameCN":"海普瑞","latestPrice":9.84,"timestamp":1721631834000,"preClose":9.86,"halted":0,"volume":6367933,"delay":0,"premium":"-67.13"}},"requestUrl":"/m/hq/s/09989/wiki","defaultTab":"wiki","newsList":[{"id":"2452446109","title":"智通AH统计|7月19日","url":"https://stock-news.laohu8.com/highlight/detail?id=2452446109","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452446109?lang=zh_cn&edition=full","pubTime":"2024-07-19 16:15","pubTimestamp":1721376907,"startTime":"0","endTime":"0","summary":"智通财经APP数据显示,截止7月19日收盘,东北电气、弘业期货、浙江世宝分列AH溢价率前三位,溢价率分别为1223.53%、558.47%、529.06%;招商银行、福耀玻璃、比亚迪股份分列AH溢价率末三位,溢价率分别为21.18%、27.10%、30.16%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1153129.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688981","02899","01919","399300","00187","06066","03678","LU0314109678.HKD","01658","LU1861214812.USD","00177","03996","02338","01375","00553","LU1251922891.USD","00042","01033","01211","06099","03143","06837","03606","02866","03908","06865","03968","002594","06869","BYDDY","IE00B29SXG58.USD","00921","09989","01349","00568","03993","00588","81211","06690","01456","06826","01057","01635","IE0008368742.USD","SG9999001093.SGD","02009","159982","02218"],"gpt_icon":1},{"id":"2452141822","title":"港股异动 | 海普瑞(09989)涨超4% 上半年净利预增超4.2倍 依诺肝素钠制剂销量稳增","url":"https://stock-news.laohu8.com/highlight/detail?id=2452141822","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452141822?lang=zh_cn&edition=full","pubTime":"2024-07-18 10:13","pubTimestamp":1721268800,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,海普瑞(09989)涨超4%,截至发稿,涨4.55%,报3.68港元,成交额438.64万港元。消息面上,海普瑞近期公布,预期2024年上半年实现归属于上市公司股东的净利润约人民币6.42亿-7.35亿元,同比增长420.70%-495.72%;预计扣非净利为约人民币3.08亿-4.01亿元,同比增长286.96%-403.20%。报告期内,公司主要产品依诺肝素钠制剂在欧洲、美国、中国等市场销量保持增长,全球市场占有率进一步提升,同时在价格体系维护良好、成本控制效率提升、原材料成本下降的共同作用下,制剂产品毛利率在剔除中国市场受集采的价格影响后,较去年同期有所提升。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1152432.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0070","09989","BK0188","HSTECH","HSCEI","YANG","BK1191","002399","BK0239"],"gpt_icon":1},{"id":"2452149577","title":"海普瑞7月16日获融资净买入1685万元 环比增加1941.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452149577","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452149577?lang=zh_cn&edition=full","pubTime":"2024-07-18 10:00","pubTimestamp":1721268017,"startTime":"0","endTime":"0","summary":"7月16日,海普瑞获融资净买入1685万元,环比上一交易日增加1941.90%。其中,融资买入2381万元,融资偿还695万元。融券方面,融券卖出2.95万股,当前融券余量为11.38万股。A股市场共有3351股获融资净买入,海普瑞净买入额排名第69。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407181004059f610fd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407181004059f610fd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","09989"],"gpt_icon":0},{"id":"2452307145","title":"单抗概念盘中拉升,海普瑞涨2.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452307145","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452307145?lang=zh_cn&edition=full","pubTime":"2024-07-18 09:39","pubTimestamp":1721266792,"startTime":"0","endTime":"0","summary":"07月18日,单抗概念盘中拉升,截至09点39分,单抗概念整体指数上涨0.62%,报1653.620点。从个股上来看,该概念的成分股中,海普瑞涨2.22%,君实生物-U、百济神州-U、信立泰涨幅居前。从资金上来看,截止发稿,单抗概念概念主力净流入为-2784.03万,其中百奥泰受到资金热捧,主力净流入128.98万;拉长时间线来看,该板块近20日主力资金净流入-13.42亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718093952941f80ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718093952941f80ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","09989"],"gpt_icon":0},{"id":"2452145302","title":"北向资金7月17日净卖出海普瑞41.08万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2452145302","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452145302?lang=zh_cn&edition=full","pubTime":"2024-07-18 09:30","pubTimestamp":1721266258,"startTime":"0","endTime":"0","summary":"7月17日,北向资金减持海普瑞41.08万股连续3日减持。截止当日收盘,深股通共持有海普瑞495.71万股,占流通股0.39%。海普瑞近5个交易日上涨13.96%,深股通累计减持118.91万股;近20个交易日上涨3.84%,深股通累计减持395.20万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407180939029f60ee84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407180939029f60ee84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","09989"],"gpt_icon":0},{"id":"2451968957","title":"净利同比暴涨4.2倍的海普瑞(09989),却只能在肝素周期中沉浮?","url":"https://stock-news.laohu8.com/highlight/detail?id=2451968957","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451968957?lang=zh_cn&edition=full","pubTime":"2024-07-16 16:44","pubTimestamp":1721119463,"startTime":"0","endTime":"0","summary":"简言之,踩在去年同期的垫脚石上,海普瑞当期实现净利同比增超4.2倍。与此同时,海普瑞A股也在当日涨停。目前,海普瑞的营业收入主要依赖国外市场。海普瑞的依诺肝素钠制剂的销售量及市场占有率因此在期内实现快速增长。而同期经调整净亏损分别达到1.84亿元和2.88亿元。同时,海普瑞还在报告期内辞去了派向君圣泰的董事职务。如果不能靠商业化阶段的创新药扛起收入大梁,以现在的收入结构看,海普瑞只能被困在肝素周期中,而这也意味","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1151507.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK0239","09989","BK0070","BK0188","002399"],"gpt_icon":0},{"id":"2451898083","title":"昨日该医药股“一”字涨停,上半年净利大幅预增逾4倍!","url":"https://stock-news.laohu8.com/highlight/detail?id=2451898083","media":"中国制药网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451898083?lang=zh_cn&edition=full","pubTime":"2024-07-16 10:18","pubTimestamp":1721096294,"startTime":"0","endTime":"0","summary":"7月15日, 海普瑞 “一”字涨停。公司表示,截至报告期末,公司已不能对君圣泰施加共同控制或重大影响,海普瑞将按照相关规定变更对君圣泰股权的会计核算方式。截至2023年12月31日,海普瑞对君圣泰的持股比例为23.61%。其中,肝素钠以及低分子肝素钠原料药营收从2022年上半年的16.11亿元下滑至2023年上半年的6.98亿元,同比下滑56.63%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071610375795c48549&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071610375795c48549&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","09939","BK1161","09989","BK1191","BK1515"],"gpt_icon":0},{"id":"2451985794","title":"海普瑞(002399)7月15日主力资金净买入223.19万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451985794","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451985794?lang=zh_cn&edition=full","pubTime":"2024-07-16 09:00","pubTimestamp":1721091659,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年7月15日收盘,海普瑞报收于9.68元,上涨10.0%,涨停,换手率0.13%,成交量1.67万手,成交额1615.86万元。近5日资金流向一览见下表:海普瑞融资融券信息显示,融资方面,当日融资买入349.45万元,融资偿还266.92万元,融资净买入82.53万元。海普瑞主营业务:肝素产业链、生物大分子CDMO和创新药物的投资、开发及商业化,致力于为全球患者带去高质量的安全有效药物和服务,护佑健康。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071600013771.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09989","002399","BK0239","BK1191","BK0188","BK0070"],"gpt_icon":0},{"id":"2451649234","title":"智通港股解盘 | 特朗普遇袭加大全球避险情绪 碧桂园(02007)或迎来转机","url":"https://stock-news.laohu8.com/highlight/detail?id=2451649234","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451649234?lang=zh_cn&edition=full","pubTime":"2024-07-15 20:04","pubTimestamp":1721045093,"startTime":"0","endTime":"0","summary":"上周六,美国前总统特朗普在宾州举行竞选集会发表演讲时遭遇袭击,引发全球关注。央行开展1000亿元1年期MLF操作,中标利率2.50%,与此前持平。2024上半年期间,挖机共计销售103213台,同比下降5.15%,其中国内53407台,同比增长4.66%,出口49806台,同比下降13.8%。另据消息称,马来西亚最高元首易卜拉欣试图振兴碧桂园位于大马柔佛州的千亿美元项目“森林城市”。优质头部影片有望促进观影需求持续释放,带动大盘票房和观影人次稳健增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1151164.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1128","LU0417516902.SGD","BK1570","LU0348735423.USD","HSTECH","BK1237","LU0417516738.SGD","02007","01896","BK1240","BK1589","07226","01193","06683","BK1521","09989","BK1507","BK1142","BK1610","BK1581","BK1221","BK1566","BK1555","BK1590","BK1598","BK1591","BK1191","LU0348825331.USD","YANG","BK1516","HSCEI","00136"],"gpt_icon":0},{"id":"2451615537","title":"肝素价格仍在低位,海普瑞遭遇诈骗后上半年却扭亏了","url":"https://stock-news.laohu8.com/highlight/detail?id=2451615537","media":"界面","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451615537?lang=zh_cn&edition=full","pubTime":"2024-07-15 16:24","pubTimestamp":1721031870,"startTime":"0","endTime":"0","summary":"7月13日晚间,海普瑞公告2024年半年度业绩预告。受此消息影响,截至7月15日收盘,海普瑞报价9.68%,涨10%。期间,海普瑞核心业务肝素及相关制剂营收随之大幅下滑。截至2024年4月,肝素出口单价仍处于历史低点。2024年上半年,海普瑞处置了联营公司君圣泰的部分股权。截至报告期末,海普瑞已不能对君圣泰施加共同控制或重大影响,海普瑞将按照相关规定变更对君圣泰股权的会计核算方式。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407151627249f4db47f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407151627249f4db47f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","09989"],"gpt_icon":0},{"id":"2451751669","title":"海普瑞:上半年净利预增超 4 倍 3.78 港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451751669","media":"和讯网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451751669?lang=zh_cn&edition=full","pubTime":"2024-07-15 10:42","pubTimestamp":1721011365,"startTime":"0","endTime":"0","summary":"【海普瑞早盘大涨 16.67%,现报 3.78 港元,成交额 1000.02 万港元。】海普瑞公布,预期该集团 2024 年上半年实现归属于上市公司股东的净利润约人民币 6.42 亿 -7.35 亿元,同比增长 420.70%-495.72%。预计扣非净利为约人民币 3.08 亿 -4.01 亿元,同比增长 286.96%-403.20%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407151052019f4c0e33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407151052019f4c0e33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09989","BK1191"],"gpt_icon":0},{"id":"2451572046","title":"海普瑞股价上涨12.65% 市值涨1.02亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451572046","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451572046?lang=zh_cn&edition=full","pubTime":"2024-07-15 09:36","pubTimestamp":1721007418,"startTime":"0","endTime":"0","summary":"2024年07月15日早盘09时36分,海普瑞股票出现波动,股价急速上涨12.65%。截至发稿,该股报3.651港元/股,成交量137.45万股,换手率0.62%,振幅4.94%。资金方面,该股资金流入138.887万港元,流出220.214万港元。海普瑞股票所在的药品行业中,整体涨幅为0.02%。消息层面,截至09时36分,海普瑞股票正面舆情新闻比例63.64%。该信息摘要如下:每经AI快讯,7月12日,海普瑞公告,预计上半年净利6.42亿元~7.35亿元,同比增长420.7%~495.7%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715093658aef9a129&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715093658aef9a129&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09989","BK1191"],"gpt_icon":0},{"id":"2451571506","title":"中报预增概念股继续活跃 台华新材、海普瑞双双竞价涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2451571506","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451571506?lang=zh_cn&edition=full","pubTime":"2024-07-15 09:31","pubTimestamp":1721007109,"startTime":"0","endTime":"0","summary":"7月15日消息,周一早盘,台华新材、海普瑞双双竞价涨停,安利股份涨超10%,汇金通、恒大高新、天德钰、远程股份、铂力特等涨超5%。消息面上,周末多家公司公布中报预告,其中台华新材预计2024年1-6月净利润盈利4亿元至4.6亿元,同比上年增长118.45%至151.21%;海普瑞预计2024年1-6月净利润盈利6.4亿元至7.34亿元,同比上年增长420.7%至495.72%。\n\n\r\n 责任编辑:栎树","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/07/15093141565258.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["603055","BK0188","BK0247","BK1191","BK0239","BK0186","BK0070","09989","002399"],"gpt_icon":0},{"id":"2451663186","title":"南向资金7月12日净买入海普瑞10.10万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2451663186","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451663186?lang=zh_cn&edition=full","pubTime":"2024-07-15 09:31","pubTimestamp":1721007099,"startTime":"0","endTime":"0","summary":"7月12日, 南向资金增持海普瑞10.10万股,连续3日增持。截止当日收盘,港股通共持有海普瑞8119.25万股,占流通股36.88%。港股通增持金额前五个股分别为建设银行、中国移动、中国联通、碧桂园服务、名创优品。海普瑞近5个交易日上涨0.93%,港股通累计增持27.25万股;近20个交易日下跌5.54%,港股通累计增持135.05万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071509443695bd434d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071509443695bd434d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09989","BK1191"],"gpt_icon":0},{"id":"2451165716","title":"海普瑞(09989)上涨14.81%,报3.72元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2451165716","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451165716?lang=zh_cn&edition=full","pubTime":"2024-07-15 09:30","pubTimestamp":1721007020,"startTime":"0","endTime":"0","summary":"7月15日,海普瑞(09989)盘中上涨14.81%,截至09:30,报3.72元/股,成交185.88万元。深圳市海普瑞药业集团股份有限公司的主要业务是覆盖肝素全产业链、生物大分子CDMO以及创新药物的投资、开发和商业化。通过这三大板块业务的相互协作,公司旨在为全球患者提供安全有效的高质量药物和服务。截至2024年一季报,海普瑞营业总收入13.73亿元、净利润1.55亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/07/15093041565178.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["09989","BK0239","BK0070","002399","BK1191","BK0188"],"gpt_icon":0},{"id":"2451961657","title":"港股异动 | 海普瑞(09989)涨超14% 预计上半年净利同比增超4.2倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2451961657","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451961657?lang=zh_cn&edition=full","pubTime":"2024-07-15 09:30","pubTimestamp":1721007009,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,海普瑞涨超14%,截至发稿,涨14.2%,报3.76港元,成交额194.79万港元。消息面上,海普瑞公布,预期该集团于2024年上半年实现归属于上市公司股东的净利润约人民币6.42亿-7.35亿元,同比增长420.70%-495.72%;预计扣非净利为约人民币3.08亿-4.01亿元,同比增长286.96%-403.20%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1150699.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK0239","HSCEI","YANG","BK0188","09989","002399","BK0070","HSTECH","07226"],"gpt_icon":0},{"id":"2450538846","title":"海普瑞上半年净利预增420.7%至495.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450538846","media":"北京商报","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450538846?lang=zh_cn&edition=full","pubTime":"2024-07-12 20:56","pubTimestamp":1720788980,"startTime":"0","endTime":"0","summary":"7月12日晚间,海普瑞(002399)发布2024年半年度业绩预告显示,公司预计上半年实现归属净利润6.42亿元至7.35亿元,比上年同期增长420.7%至495.72%。海普瑞表示,报告期内,肝素产业链经营环境有所改善,市场需求出现回暖迹象。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202407123130012422.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202407123130012422.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1191","09989"],"gpt_icon":0},{"id":"2450583031","title":"海普瑞预计上半年净利润增长420.70%—495.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450583031","media":"新京报","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450583031?lang=zh_cn&edition=full","pubTime":"2024-07-12 18:57","pubTimestamp":1720781832,"startTime":"0","endTime":"0","summary":"7月12日,海普瑞发布2024年半年度业绩预告,预计报告期内实现归属于上市公司股东的净利润6.42亿元—7.35亿元,比上年同期增长420.70%—495.72%。公告披露,报告期内,肝素产业链经营环境有所改善,市场需求出现回暖迹象。海普瑞积极落实品牌出海战略,肝素制剂业务发展态势良好,主要产品依诺肝素钠制剂在欧洲、美国、中国等市场的销量继续保持增长,全球市场占有率进一步提升。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202407123129924796.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202407123129924796.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["09989"],"gpt_icon":0},{"id":"2450830165","title":"海普瑞(002399.SZ)发预增,预计上半年净利润6.42亿元–7.35亿元,同比这种420.70%-495.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450830165","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450830165?lang=zh_cn&edition=full","pubTime":"2024-07-12 17:26","pubTimestamp":1720776388,"startTime":"0","endTime":"0","summary":"智通财经APP讯,海普瑞 发布2024年半年度业绩预告,公司预计上半年归属于上市公司股东的净利润6.42亿元–7.35亿元,同比这种420.70%-495.72%;扣除非经常性损益后的净利润3.08亿元–4.01亿元,同比增长286.96%-403.20%。同时,在价格体系维护良好、成本控制效率提升、原材料成本下降的共同作用下,制剂产品毛利率在剔除中国市场受集采的价格影响后,较去年同期有所提升。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1150080.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09989","002399"],"gpt_icon":0},{"id":"2450030694","title":"海普瑞:上半年净利预增420.7%~495.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450030694","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450030694?lang=zh_cn&edition=full","pubTime":"2024-07-12 16:59","pubTimestamp":1720774751,"startTime":"0","endTime":"0","summary":"每经AI快讯,7月12日,海普瑞公告,预计上半年净利6.42亿元~7.35亿元,同比增长420.7%~495.7%。报告期内,肝素产业链经营环境有所改善,市场需求出现回暖迹象。公司积极落实品牌出海战略,发挥海内外营销网络布局优势,肝素制剂业务发展态势良好,主要产品依诺肝素钠制剂在欧洲、美国、中国等市场的销量继续保持增长,全球市场占有率进一步提升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202407123129809413.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202407123129809413.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["09989","BK1191"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0572},{"period":"1month","weight":0.0237},{"period":"3month","weight":0.1849},{"period":"6month","weight":0.3008},{"period":"1year","weight":-0.1722},{"period":"ytd","weight":-0.0335}],"compareEarnings":[{"period":"1week","weight":-0.0211},{"period":"1month","weight":-0.0218},{"period":"3month","weight":0.048},{"period":"6month","weight":0.1092},{"period":"1year","weight":-0.0755},{"period":"ytd","weight":0.0345}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"深圳市海普瑞药业集团股份有限公司是一家中国制药公司。该公司经营四个分部。药物制剂分部从事生产和销售抗凝血及抗血栓药物制剂,包括依诺肝素钠注射液和肝素钠注射液。Active Pharmaceutical Ingredient(API)分部从事生产和销售API产品,包括肝素钠API和依诺肝素钠API。Contract Development Manufacturing Organization(CDMO)分部提供药物开发所需要的全周期服务,包括研发、生产、质量管理、项目管理以及商业化生产。该公司还经营其他分部。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.086695},{"month":2,"riseRate":0.5,"avgChangeRate":0.033287},{"month":3,"riseRate":0.25,"avgChangeRate":-0.076508},{"month":4,"riseRate":0.5,"avgChangeRate":0.037874},{"month":5,"riseRate":0.75,"avgChangeRate":-0.002827},{"month":6,"riseRate":0.25,"avgChangeRate":0.004312},{"month":7,"riseRate":0.25,"avgChangeRate":-0.033522},{"month":8,"riseRate":0.25,"avgChangeRate":-0.023829},{"month":9,"riseRate":0,"avgChangeRate":-0.100348},{"month":10,"riseRate":0.25,"avgChangeRate":-0.04992},{"month":11,"riseRate":0.25,"avgChangeRate":0.003644},{"month":12,"riseRate":0.25,"avgChangeRate":-0.022218}],"exchange":"SEHK","name":"海普瑞","nameEN":"HEPALINK"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海普瑞(09989)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海普瑞(09989)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海普瑞,09989,海普瑞股票,海普瑞股票老虎,海普瑞股票老虎国际,海普瑞行情,海普瑞股票行情,海普瑞股价,海普瑞股市,海普瑞股票价格,海普瑞股票交易,海普瑞股票购买,海普瑞股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海普瑞(09989)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海普瑞(09989)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}